000			02132 a2200637 4500
005			20250515054753.0
264		0	_c20070330
008			200703s 0 0 eng d
022			_a0360-4039
040			_aNLM _beng _cNLM
100	1		_aHussar, Daniel A
245	0	0	_aNew drugs 07, part I. _h[electronic resource]
260			_bNursing _cFeb 2007
300			_a51-8; quiz 59-60 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAbatacept
650	0	4	_aAcetanilides _xtherapeutic use
650	0	4	_aAlprostadil _xanalogs & derivatives
650	0	4	_aAnidulafungin
650	0	4	_aAntidiuretic Hormone Receptor Antagonists
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aArabinonucleosides _xtherapeutic use
650	0	4	_aBenzazepines _xtherapeutic use
650	0	4	_aBenzenesulfonates _xtherapeutic use
650	0	4	_aDrug Approval
650	0	4	_aDrug Interactions
650	0	4	_aDrug Monitoring
650	0	4	_aDrug Therapy _xnursing
650	0	4	_aEchinocandins
650	0	4	_aFatty Acids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xtherapeutic use
650	0	4	_aImmunoconjugates _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aInsulin _xanalogs & derivatives
650	0	4	_aInsulin Detemir
650	0	4	_aInsulin, Long-Acting
650	0	4	_aIntercellular Signaling Peptides and Proteins _xtherapeutic use
650	0	4	_aLenalidomide
650	0	4	_aLubiprostone
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPatient Education as Topic
650	0	4	_aPeptides, Cyclic _xtherapeutic use
650	0	4	_aPhenylurea Compounds
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aRanolazine
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aThalidomide _xanalogs & derivatives
650	0	4	_aUnited States
773	0		_tNursing _gvol. 37 _gno. 2 _gp. 51-8; quiz 59-60
999			_c16833908 _d16833908